Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

IT

Corporate venturing deal net: 28 January-1 February 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.


Feb 1, 2019

Pliops prises $30m in series B

SoftBank, Western Digital, Xilinx and existing backer Intel all invested, as the cloud storage technology developer increased its overall funding to $40m.

Feb 1, 2019

Fortanix forges $23m series B round

Intel Capital has led a $23m series B round for Fortanix, with the corporate venture capital unit’s Sunil Kurkure joining the encryption technology developer's board of directors.

Feb 1, 2019

Verbit translates ClalTech interest into $23m

ClalTech has taken part in a Viola Ventures-led series A round to increase the AI-based speech translation platform's total funding to $34m.

Feb 1, 2019

Questions for the Future

Introduction to the World of Corporate Venturing 2019

Feb 1, 2019

NumberAI calls in Gradient for series A

Costanoa Ventures has led a $10.5m round for the landline-based smart messaging platform that also featured Alphabet's AI-focused Gradient Ventures fund.

Jan 31, 2019

Lifetime award: Barbara Dalton, Pfizer

After a quarter of a century of healthcare investing, Barbara Dalton, senior managing partner of Pfizer Ventures, has won the Global Corporate Venturing Lifetime Achievement Award 2019.

Jan 31, 2019

Welcome to the Global Corporate Venturing Awards 2019

Introduction to the GCV awards 2019 by James Mawson, editor in chief

Jan 31, 2019

IPO of the Year: DocuSign

A leading company in the e-signature and digital transaction management space, San Francisco-based DocuSign went public in April last year, with a market capitalization of $4.4bn.

Jan 31, 2019

M&A of the Year: Prexton Therapeutics

Having emerged from the Merck Serono Entrepreneur Partnership Program (EPP) in 2015, Prexton Therapeutics raised a total $41m of funding before it was acquired by pharmaceutical firm Lundbeck for an estimated $1.1bn last year.

Jan 31, 2019

Sub-$50m Investment of the Year: Maana

Maana recently won GCV’s inaugural award for energy-tech corporate venture capital (CVC) investment of the year, presented during its Venture Houston conference in November. Now, Maana has gone one-stage further and won the Sub-$50m Investment of the Year award across all industries.

Jan 31, 2019

New Entrant of the Year: Severstal Ventures

In May last year, Severstal announced the launch of Severstal Ventures – a corporate venture fund that would invest directly as well as through other funds in advanced materials and associated technologies, in Russia and abroad.

Jan 31, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here